Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Mao Simon J T"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Acute Phase Proteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a345810ba0cef372afa1cd48157c6cc3
https://doi.org/10.5772/56048
https://doi.org/10.5772/56048
Autor:
Richard L. Jackson, Roger L. Barnhart, S J Busch, Mark T. Yates, M. C. Fitzgerald, G A Martin, Craig E. Thomas, Mao Simon J T
Publikováno v:
Journal of Biological Chemistry. 269:16376-16382
We have produced a line of transgenic mice expressing human hepatic triglyceride lipase (hH-TGL) to examine the in vivo effects of hepatic lipase expression on high density lipoprotein catabolism. Activation of metallothionine I promoter-hH-TGL cDNA
Publikováno v:
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 11:1266-1275
Probucol is a drug that lowers plasma cholesterol in both humans and animals. In low density lipoprotein (LDL) receptor-deficient Watanabe rabbits, probucol reduces the progression of atherosclerosis. This effect may be attributed to the antioxidant
Autor:
Mao Simon J T, Michelle A. Tucci
Publikováno v:
Analytical Biochemistry. 192:6-10
The present study describes a simple, quantitative assay for measuring the lysis of a plasma clot. The principle of the assay is based on the release of Coomassie brilliant blue R-250 dye from the clot. Thirty microliters of freshly prepared Coomassi
Publikováno v:
Journal of Medicinal Chemistry. 34:298-302
Probucol (1) and probucol analogues with the substitutions at the disulfide-linked carbon (2, 3) and an additional substitution at a tert-butyl of each phenolic ring (4) were tested for their ability to lower total serum cholesterol and prevent aorti
Autor:
Marguerite H. Payne, Mao Simon J T, John L. Krstenansky, Robert J. Broersma, Thomas J. Owen, Mark T. Yates
Publikováno v:
Thrombosis and Haemostasis. 63:208-214
SummaryMDL 28,050 is a decapeptide antithrombin agent that inhibits a-thrombin-induced fibrin clot formation by binding to a non-catalytic site on α-thromhin. It is the result of chemical and structural optimization of a functional domain of the lee
Publikováno v:
Thrombosis and Haemostasis. 63:445-448
SummaryA peptide, Gly-Pro-Arg-Val-Val-Glu, corresponding to the first six residues of the amino terminus of the a-chain of human fibrin (desAA-fihrin) was prepared by solid-phase peptide synthesis. The peptide was covalently linked to keyhole-limpet
Publisher Summary Probucol [bis(3,5-di- tert -butyl-4-hydroxyphenylthio)propane] is a marketed cholesterol-lowering agent that has been shown to be a potent antioxidant. The antioxidant activity of probucol inhibits the formation of oxidatively modif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3ba1877cee1cd622b3ea42c1f1576ae
https://doi.org/10.1016/0076-6879(94)34122-2
https://doi.org/10.1016/0076-6879(94)34122-2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.